Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [GROseq]. Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [GROseq]
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA908801
下载链接
链接失效反馈官方服务：
资源简介：
Nascent transcription and enhancer activity was studied using GRO-seq in the acute lymphoblastic leukemia cell line RS4;11 upon inhibition of the WEE1 kinase. Overall design: GRO-seq profiles were generated from RS4;11 cell line after 4, 10 and 24 h WEE1 inhibition by AZD1775. DMSO treated cells were used as controls.
创建时间：
2022-12-05
